Valutazione di alterazioni latenti della coagulazione mediante il dosaggio plasmatico del complesso trombina antitrombina nelle neoplasie gastrointestinali.

L. Guidi; C. Bartoloni; P. Pellicanò; A. Cappelli; F. Cursi; R. Pili; A. Tricerri; F. Patriarca; G. Gambassi

Valutazione di alterazioni latenti della coagulazione mediante il dosaggio plasmatico del complesso trombina antitrombina nelle neoplasie gastrointestinali.

Translated title of the contribution: Evaluation of latent changes in blood coagulation by the determination of plasma thrombin-antithrombin complex in gastrointestinal neoplasms

L. Guidi
, C. Bartoloni
, P. Pellicanò
, A. Cappelli
, F. Cursi
, R. Pili
, A. Tricerri
, F. Patriarca
, G. Gambassi

Medicine

University at Buffalo

Catholic University of the Sacred Heart

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

The relationship between cancer and coagulation disorders is widely accepted. Such disorders can contribute to the metastatic spreading of the primary tumor. Aim of our study was to evaluate the alterations of thrombin-antithrombin III complex (TAT) measured by an ELISA plasma assay in a population of 78 patients suffering from various gastrointestinal tumors. We found high levels of TAT in 68.6% of the patients. Our data show that assay of TAT plasma levels may be a useful test in detecting early coagulation disorders in cancer patients.

Translated title of the contribution	Evaluation of latent changes in blood coagulation by the determination of plasma thrombin-antithrombin complex in gastrointestinal neoplasms
Original language	Undefined/Unknown
Pages (from-to)	367-373
Number of pages	7
Journal	La Clinica terapeutica
Volume	136
Issue number	6
State	Published - Mar 31 1991

Cite this

@article{253efbf8892042ddb40b9567a85e9d6e,

title = "Valutazione di alterazioni latenti della coagulazione mediante il dosaggio plasmatico del complesso trombina antitrombina nelle neoplasie gastrointestinali.",

abstract = "The relationship between cancer and coagulation disorders is widely accepted. Such disorders can contribute to the metastatic spreading of the primary tumor. Aim of our study was to evaluate the alterations of thrombin-antithrombin III complex (TAT) measured by an ELISA plasma assay in a population of 78 patients suffering from various gastrointestinal tumors. We found high levels of TAT in 68.6\% of the patients. Our data show that assay of TAT plasma levels may be a useful test in detecting early coagulation disorders in cancer patients.",

author = "L. Guidi and C. Bartoloni and P. Pellican{\`o} and A. Cappelli and F. Cursi and R. Pili and A. Tricerri and F. Patriarca and G. Gambassi",

year = "1991",

month = mar,

day = "31",

language = "Undefined/Unknown",

volume = "136",

pages = "367--373",

journal = "La Clinica terapeutica",

issn = "0009-9074",

publisher = "Societa Editrice Universo",

number = "6",

}

TY - JOUR

T1 - Valutazione di alterazioni latenti della coagulazione mediante il dosaggio plasmatico del complesso trombina antitrombina nelle neoplasie gastrointestinali.

AU - Guidi, L.

AU - Bartoloni, C.

AU - Pellicanò, P.

AU - Cappelli, A.

AU - Cursi, F.

AU - Pili, R.

AU - Tricerri, A.

AU - Patriarca, F.

AU - Gambassi, G.

PY - 1991/3/31

Y1 - 1991/3/31

N2 - The relationship between cancer and coagulation disorders is widely accepted. Such disorders can contribute to the metastatic spreading of the primary tumor. Aim of our study was to evaluate the alterations of thrombin-antithrombin III complex (TAT) measured by an ELISA plasma assay in a population of 78 patients suffering from various gastrointestinal tumors. We found high levels of TAT in 68.6% of the patients. Our data show that assay of TAT plasma levels may be a useful test in detecting early coagulation disorders in cancer patients.

AB - The relationship between cancer and coagulation disorders is widely accepted. Such disorders can contribute to the metastatic spreading of the primary tumor. Aim of our study was to evaluate the alterations of thrombin-antithrombin III complex (TAT) measured by an ELISA plasma assay in a population of 78 patients suffering from various gastrointestinal tumors. We found high levels of TAT in 68.6% of the patients. Our data show that assay of TAT plasma levels may be a useful test in detecting early coagulation disorders in cancer patients.

UR - https://www.scopus.com/pages/publications/0026434533

M3 - Article

C2 - 1828201

SN - 0009-9074

VL - 136

SP - 367

EP - 373

JO - La Clinica terapeutica

JF - La Clinica terapeutica

IS - 6

ER -

Valutazione di alterazioni latenti della coagulazione mediante il dosaggio plasmatico del complesso trombina antitrombina nelle neoplasie gastrointestinali.

Abstract

Other files and links

Fingerprint

Cite this